Myeloproliferative neoplasms: open trials in Brazil

• NCT04877522

  Asciminib Roll-over Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Rio de Janeiro · São Paulo

  Registry updated 2026-11-09

• NCT07357727

  A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Barretos · Curitiba · Grupo ELORA, Florianópolis · Goiânia

  Registry updated 2026-11-06

• NCT07623161

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  Trial Treatment · Phase 3 · Takeda

  Grupo Elora Pesquisa Clinica, Florianópolis · Hospital Amaral Carvalho (HAC), Jaú · Centro de Hematologia e Oncologia (CHO), Joinville · Hospital Mae de Deus Integrated Oncology Center, Porto Alegre · Hospital Sao Lucas da PUCRS, Porto Alegre · Porto Alegre Clinical Hospital (HCPA), Porto Alegre · Centro de Ensino, Pesquisa e Inovacao do Hospital Sao Lucas (CEPIN HSL RJ / Rede Americas), Rio de Janeiro · Portuguese Charity of Sao Paulo, São Paulo · IEP São Lucas, São Paulo

  Registry updated 2026-11-06

• NCT07429266

  INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

  Trial Treatment · Phase 3 · Ono Pharmaceutical Co., Ltd.

  Hospital Ophir Loyola, Belém · Meso Clinic Servicos Medicos Ltda, Blumenau · Instituto Joinvilense de Hematologia e Oncologia LTDA, Santa Catarina

  Registry updated 2026-10-29

• NCT05037760

  A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis

  Trial Treatment · Phase 2 · Takeda

  Hospital de Clinicas de Porto Alegre, Porto Alegre · IMV-Pesquisa Cardiologica Sociedade Simples, Porto Alegre · Albert Einstein Sociedade Beneficente Israelita Brasiliera, São Paulo · Instituto de Ensino e Pesquisas Sao Lucas, São Paulo · Hospital Das Clinicas Da Faculdade de Medicina Da U S P, São Paulo · Hospital Beneficência Portuguesa de São Paulo, São Paulo

  Registry updated 2026-02-05

All Myeloproliferative neoplasms trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error